Investors looking for stocks that can produce eye-popping gains in a short time frame often turn toward biotechnology stocks. In this wonky industry, encouraging results from a clinical trial can turn ...

Transcutaneous afferent patterned stimulation is linked to metabolic activity changes in the cerebellum and other brain areas ...

The company plans to conduct a three-year study of Parkinson's risk among people with essential tremor, using its Syn-One Test.

Praxis Precision Medicines Inc. (NASDAQ: PRAX) is one of the Reddit stocks that will go to the moon. On October 16, Praxis ...

Topline data were announced from two phase 3 trials evaluating ulixacaltamide in patients with essential tremor.

Shares of Praxis Precision Medicines skyrocketed 184% Thursday on "groundbreaking" test results for an essential tremor ...

Shares of Praxis Precision Medicines more than tripled Thursday, peaking at $200 apiece, after the company disclosed positive ...

Praxis Precision Medicines’ commitment to forging ahead with ulixacaltamide in essential tremor (ET) has paid off. | The ...

Early investigators began testing how focused ultrasound could treat neurological disorders, pain and even cancer. open image ...

Praxis Precision Medicines said on Thursday its experimental drug for movement disorder helped improve daily functioning in patients in two late-stage trials, sending its shares surging more than ...

AbbVie (NYSE:ABBV) announced that its mid-stage study of Botox (onabotulinumtoxinA) for treating essential tremor in the upper limbs achieved its main goal. The research successfully reached its ...